INTRODUCTION: To investigate the trends in the performance of radical cystectomy (RC) versus partial cystectomy (PC) in the United States over the past 10 years and compare postoperative outcomes between two procedures. MATERIALS AND METHODS: The data was captured from the Nationwide Inpatient Sample (NIS) 2001-2010 using the appropriate ICD-9-CM diagnosis and procedure codes. Patient sociodemographics, comorbidities and in-hospital complications after PC and RC were compared, taking into account some hospital characteristics. A chi-square analysis including a Cochran-Armitage trend test and a multivariable logistic regression analysis were employed. RESULTS: RC rate increased from 84.8% in 2001 to 90.3% in 2010, while PC decreased from 15.2% to 9.7% (p < 0.0001). PC patients were older than their RC counterparts (72.1 ± 11.3 versus 68.6 ± 10.1 years; p < 0.0001), had higher prevalence of major comorbidities, but decreased rate of postoperative complications overall (21.3% versus 38.6%; p < 0.001). The greatest rates of PC utilization were found in the Northeast and South (12.8% and 12.7%). The frequency of PC was 18.9% in non-teaching hospitals compared to 9.0% in teaching hospitals (p < 0.0001). In multivariate analysis, females, octogenarians, patients with hypertension and obesity, and patients in non-teaching and rural hospitals were more likely to receive PC. CONCLUSIONS: Despite the potential advantages in cancer control offered by RC, PC is being performed more frequently on the elderly, female patients, patients with hypertension and obesity, in non-teaching and rural hospitals, and in certain United States geographic regions, which can be partially explained by disparities in access to high volume cancer centers.
INTRODUCTION: To investigate the trends in the performance of radical cystectomy (RC) versus partial cystectomy (PC) in the United States over the past 10 years and compare postoperative outcomes between two procedures. MATERIALS AND METHODS: The data was captured from the Nationwide Inpatient Sample (NIS) 2001-2010 using the appropriate ICD-9-CM diagnosis and procedure codes. Patient sociodemographics, comorbidities and in-hospital complications after PC and RC were compared, taking into account some hospital characteristics. A chi-square analysis including a Cochran-Armitage trend test and a multivariable logistic regression analysis were employed. RESULTS:RC rate increased from 84.8% in 2001 to 90.3% in 2010, while PC decreased from 15.2% to 9.7% (p < 0.0001). PCpatients were older than their RC counterparts (72.1 ± 11.3 versus 68.6 ± 10.1 years; p < 0.0001), had higher prevalence of major comorbidities, but decreased rate of postoperative complications overall (21.3% versus 38.6%; p < 0.001). The greatest rates of PC utilization were found in the Northeast and South (12.8% and 12.7%). The frequency of PC was 18.9% in non-teaching hospitals compared to 9.0% in teaching hospitals (p < 0.0001). In multivariate analysis, females, octogenarians, patients with hypertension and obesity, and patients in non-teaching and rural hospitals were more likely to receive PC. CONCLUSIONS: Despite the potential advantages in cancer control offered by RC, PC is being performed more frequently on the elderly, female patients, patients with hypertension and obesity, in non-teaching and rural hospitals, and in certain United States geographic regions, which can be partially explained by disparities in access to high volume cancer centers.
Authors: Danielle A Southern; Barbara Roberts; Alun Edwards; Stafford Dean; Peter Norton; Lawrence W Svenson; Erik Larsen; Peter Sargious; David C W Lau; William A Ghali Journal: Can J Public Health Date: 2010 Jan-Feb
Authors: Max Kates; Michael A Gorin; Christopher M Deibert; Phillip M Pierorazio; Mark P Schoenberg; James M McKiernan; Trinity J Bivalacqua Journal: Urol Oncol Date: 2013-11-13 Impact factor: 3.498
Authors: Florian Roghmann; Shyam Sukumar; Praful Ravi; Vincent Q Trinh; Malek Meskawi; Khurshid R Ghani; Jesse D Sammon; Ariella A Friedman; James O Peabody; Mani Menon; Joachim Noldus; Pierre I Karakiewicz; Maxine Sun; Quoc-Dien Trinh Journal: Urol Int Date: 2013-09-19 Impact factor: 2.089
Authors: John J Knoedler; Stephen A Boorjian; Simon P Kim; Christopher J Weight; Prabin Thapa; Robert F Tarrell; John C Cheville; Igor Frank Journal: J Urol Date: 2012-08-15 Impact factor: 7.450
Authors: Umberto Capitanio; Hendrik Isbarn; Shahrokh F Shariat; Claudio Jeldres; Laurent Zini; Fred Saad; Markus Graefen; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz Journal: Urology Date: 2009-07-22 Impact factor: 2.649
Authors: Ross J Mason; Igor Frank; Bimal Bhindi; Matthew K Tollefson; R Houston Thompson; R Jeffrey Karnes; Robert Tarrell; Prabin Thapa; Stephen A Boorjian Journal: World J Urol Date: 2017-09-14 Impact factor: 4.226
Authors: Emanuele Zaffuto; Marco Bandini; Stéphanie Gazdovich; Anne-Sophie Valiquette; Sami-Ramzi Leyh-Bannurah; Zhe Tian; Paolo Dell'Oglio; Markus Graefen; Marco Moschini; Andrea Necchi; Shahrokh F Shariat; Alberto Briganti; Francesco Montorsi; Pierre I Karakiewicz Journal: World J Urol Date: 2018-04-27 Impact factor: 4.226